A recent opposition decision by the New Zealand Patent Office in Resmed Pty Ltd v Fisher & Paykel Healthcare Limited [2026] NZIPOPAT 6 provides a useful reminder of how divisional patent practice in New Zealand differs from that in Australia, and the traps unsuspecting applicants can fall into in both jurisdictions.While not the substance of the Resmed decision, the Assistant Commissioner
Kat-approved networkingThe Katfriends at Kisaco Research wish to inform IPKat readers that the Life Science Legal Strategy Summit is relocating to Frankfurt for 2026, taking place at the Frankfurt Marriott Hotel on 13-14 October. The agenda is available here.Now in its 5th edition, the Life Science Legal Strategy Summit unites together in-house counsel with law firms, regulators, judges and more
Darren Meale of Simmons & Simmons presents the eighteenth volume of his rundown of notable trade mark cases over the past six months:Retromark Volume XVIII: the last six months in trade marksby Darren MealeWe’re back with another bumper volume of trade mark judgments. In an era where long-form writing is slowly (or maybe I should say swiftly) being replaced by generative AI, I can hold my
If you are a lawyer, chances are you have at some point submitted a form with publishable and confidential matters you have handled to a legal directory, invited colleagues and clients to recommend you, recommended colleagues yourself or proudly displayed a badge of the legal directory that ranked you on your firm's website or in your email signature. The recent decision Top-Mediziner of the
In a recent interlocutory decision in EOS Defence Systems Pty Limited v Pahlavani [2026] FCA 688, the Federal Court of Australia ordered the withdrawal of a PCT application and associated provisional application before publication. This unusual decision highlights the importance of confidentiality and IP obligations in employment contracts as a means of preventing employees from publishing
In 2023, two members of the SHEIN group of companies issued proceedings against the newcomer of the e-commerce world, Temu. Temu was relatively unknown in the UK at the time, having only launched there in April 2023. Its aggressive pricing, combined with a mind-boggling array of products and gamified sales experience, launched it into the consumer consciousness quickly. SHEIN is the relative
The loss of market share we are already seeing for on-market cell therapy products is a result of in-class competitors for the same target and indication from rival innovator companies, not copycat products with identical CAR sequences. In such a market, sequence-limited composition-of-matter protection of the CAR sequence may have limited value. We are now seeing this play out at the UPC, with
August is supposed to be the quiet month. Somebody ought to tell the courts of Europe. In recent weeks, the same heart failure drug has had its SPC upheld in two jurisdictions on two quite different grounds of attack, the UPC has declined to wait for a French court, and a Dutch pharmacy has found where the compounding exemption stops.Entresto twice over: UK and Greece arrive at the same placeIn
Welcome to August! Whether you are sunning yourself on a beach or stuck in a sweltering office, it can be hard to keep up with the steady stream of intellectual property developments. Fear not, as this Kat is here to round up everything published on the blog last week.Managing global IP law from the garden patio.PatentsJocelyn Bosse reviewed “Pharmaceutical, Biological and Chemical Patents: A
The IPKat has received and is pleased to host the review of “Copyright, Contract, and Video Games: Terms of Play” written by Amy Thomas. This book review has been prepared by Katfriend Sarath Ninan Mathew (University of Oxford). Here is what Sarath writes: Amy Thomas’s Copyright, Contract, and Video Games: Terms of Play analyses the licensing agreements used by thirty popular video
Can a domain name infringe a national trade mark where nobody in the protected territory can and is supposed to see website connected to the domain name? In the new reference Fassbinderei (case C-584/26) from Austria, the Court of Justice of the EU (“CJEU”) is asked to determine whether a geo-blocked website operating under a .at domain name and expressly excluding Austrian customers, is